{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:47:53Z","timestamp":1791276473047,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.jaad.2014.10.023","type":"journal-article","created":{"date-parts":[[2014,12,3]],"date-time":"2014-12-03T05:56:05Z","timestamp":1417586165000},"page":"314-320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Voriconazole phototoxicity in children: A retrospective review"],"prefix":"10.1016","volume":"72","author":[{"given":"Johanna","family":"Sheu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena B.","family":"Hawryluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy B.","family":"London","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer T.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2014.10.023_bib1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1086\/367933","article-title":"Voriconazole: a new triazole antifungal agent","volume":"36","author":"Johnson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2014.10.023_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaad.2009.09.033","article-title":"Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole","volume":"62","author":"Cowen","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.10.023_bib3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/INF.0b013e3182566311","article-title":"Voriconazole-induced phototoxicity in children","volume":"31","author":"Bernhard","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaad.2014.10.023_bib4","unstructured":"Vfend (voriconazole) [product labeling information]. New York, NY: Pfizer Inc; 2014."},{"key":"10.1016\/j.jaad.2014.10.023_bib5","unstructured":"FDA Antiviral Drugs Advisory Committee. Briefing Document for Voriconazole. (Oral and Intravenous formulations), 2001. Available at: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/01\/briefing\/3792b2_01_Pfizer.pdf. Accessed November 12, 2014."},{"key":"10.1016\/j.jaad.2014.10.023_bib6","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/jac\/dks258","article-title":"Monitoring of voriconazole plasma concentrations in immunocompromised pediatric patients","volume":"67","author":"Pieper","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaad.2014.10.023_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00006454-200203000-00015","article-title":"Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive\u00a0fungal infections in children","volume":"21","author":"Walsh","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaad.2014.10.023_bib8","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/pbc.24897","article-title":"Phototoxic dermatoses in pediatric BMT patients receiving voriconazole","volume":"61","author":"Goyal","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaad.2014.10.023_bib9","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1128\/AAC.00068-13","article-title":"Severe skin toxicity in pediatric oncology patients treated with voriconazole and concomitant methotrexate","volume":"57","author":"van Hasselt","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2014.10.023_bib10","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1093\/cid\/cit600","article-title":"A multistep voriconazole-related phototoxic pathway may lead to skin carcinoma: results from a French nationwide study","volume":"57","author":"Epaulard","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2014.10.023_bib11","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.healun.2012.02.033","article-title":"High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients","volume":"31","author":"Singer","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jaad.2014.10.023_bib12","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.healun.2010.05.022","article-title":"Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients","volume":"29","author":"Vadnerkar","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jaad.2014.10.023_bib13","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.healun.2012.05.003","article-title":"Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole","volume":"31","author":"Feist","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jaad.2014.10.023_bib14","doi-asserted-by":"crossref","first-page":"E200","DOI":"10.1111\/petr.12320","article-title":"Cutaneous squamous cell carcinoma in two pediatric lung transplant patients on prolonged voriconazole treatment","volume":"18","author":"Wong","year":"2014","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jaad.2014.10.023_bib15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MPH.0b013e31828e5d96","article-title":"Nonmelanoma skin cancer in childhood after hematopoietic stem cell transplant: a report of 4 cases","volume":"36","author":"Rork","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaad.2014.10.023_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1124\/dmd.31.5.540","article-title":"Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole","volume":"31","author":"Hyland","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jaad.2014.10.023_bib17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/AAC.01123-08","article-title":"Comprehensive in\u00a0vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A","volume":"53","author":"Jeong","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2014.10.023_bib18","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1365-2230.2001.00909.x","article-title":"Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole","volume":"26","author":"Denning","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2014.10.023_bib19","doi-asserted-by":"crossref","first-page":"e40754","DOI":"10.1371\/journal.pone.0040754","article-title":"Distinct innate immune gene expression profiles in non-melanoma skin cancer of immunocompetent and immunosuppressed patients","volume":"7","author":"Muehleisen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2014.10.023_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-6143.2012.04292.x","article-title":"A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population","volume":"13","author":"Harwood","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jaad.2014.10.023_bib21","series-title":"Andrews' Diseases of the Skin Clinical Dermatology","first-page":"633","article-title":"Epidermal Nevi, Neoplasms, and Cysts","author":"James","year":"2011"},{"key":"10.1016\/j.jaad.2014.10.023_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jaad.2010.11.062","article-title":"Skin cancer in solid organ transplant recipients: advances in therapy and management, part I: epidemiology of skin cancer in solid organ transplant recipients","volume":"65","author":"Zwald","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.10.023_bib23","first-page":"1383","article-title":"De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation","volume":"25","author":"Sheil","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2014.10.023_bib24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10096-013-1998-2","article-title":"Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation","volume":"33","author":"Doring","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jaad.2014.10.023_bib25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1086\/422729","article-title":"Zygomycosis: reemergence of an old pathogen","volume":"39","author":"Kauffman","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2014.10.023_bib26","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJM200402263500923","article-title":"Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants","volume":"350","author":"Marty","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2014.10.023_bib27","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1086\/423274","article-title":"Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole","volume":"39","author":"Imhof","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2014.10.023_bib28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/422723","article-title":"Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis","volume":"39","author":"Siwek","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2014.10.023_bib29","doi-asserted-by":"crossref","first-page":"442","DOI":"10.7326\/0003-4819-153-7-201010050-00007","article-title":"Screening and\u00a0surveillance for second malignant neoplasms in adult\u00a0survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"153","author":"Nathan","year":"2010","journal-title":"Ann Intern Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214020994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214020994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:34:41Z","timestamp":1759271681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962214020994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0190962214020994"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2014.10.023","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Voriconazole phototoxicity in children: A retrospective review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2014.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}